FILE:SYK/SYK-8K-20040715160404.txt.gz
EVENTS:	
TEXT:
ITEM: 
 
Stryker Corporation issued a press release on July 15, 2004 announcing its second quarter and first half 2004 operating results.  A copy of this press release is attached hereto as Exhibit 99.1.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 

Exhibit 99.1  
 
 
Kalamazoo, Michigan -- July 15, 2004 -- Stryker Corporation (NYSE:SYK) reported today that net sales were $1,043.0 million for the second quarter of 2004, representing a 17% increase over net sales of $891.7 million in the second quarter of 2003 and $2,078.1 million for the first half of 2004, representing a 20% increase over net sales of $1,738.6 million for the first half of 2003.  Excluding the impact of foreign currency, net sales increased 14% for the second quarter and 16% for the first half.
Net earnings for the second quarter of 2004 were $152.7 million, representing a 42% increase over net earnings of $107.5 million in the second quarter of 2003.  Diluted net earnings per share for the second quarter increased 42% to $.37 compared to $.26 in the second quarter of 2003.  Net earnings for the first half of 2004 were $288.6 million, representing a 36% increase over net earnings of $211.6 million in 2003.  Diluted net earnings per share for the first half increased 35% to $.70 compared to $.52 in the first half of 2003. 
 
Domestic sales were $677.2 million for the second quarter and $1,335.1 million for the first half of 2004, representing increases of 19% and 20%, respectively, as a result of strong shipments of Orthopaedic Implants and MedSurg Equipment and higher revenue from Physical Therapy Services.
International sales were $365.8 million for the second quarter and $743.0 million for the first half of 2004, representing increases of 13% and 19%, respectively, as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment.  The impact of foreign currency comparisons to the dollar value of international sales was favorable by $23.2 million in the second quarter and by $69.9 million in the first half.  Excluding the impact of foreign currency, international sales increased 6% in the second quarter and 8% in the first half.
Worldwide sales of Orthopaedic Implants were $630.9 million for the second quarter and $1,264.0 million for the first half of 2004, representing increases of 15% and 19%, respectively, based on higher shipments of reconstructive (hip, knee and shoulder), trauma, spine and micro implant systems and bone cement.  Excluding the impact of foreign currency, sales of Orthopaedic Implants increased 12% in the second quarter and 14% in the first half.
Worldwide sales of MedSurg Equipment were $349.5 million for the second quarter and $691.1 million for the first half of 2004, representing increases of 21% in both periods based on higher shipments of powered surgical instruments, endoscopic products, patient handling and emergency medical equipment and surgical navigation systems.  Excluding the impact of foreign currency, sales of MedSurg Equipment increased 20% in the second quarter and 19% in the first half.
Physical Therapy Services revenues were $62.6 million for the second quarter and $123.0 million for the first half of 2004, representing increases of 11% and 13%, respectively, as a result of revenue from new physical therapy centers and higher revenues from existing centers.
The Company's effective income tax rate for the second quarter and first half of 2004 was reduced to 30.0% as compared to a 31.0% effective income tax rate for the second quarter and first half of 2003 and an effective annual income tax rate of 30.5% for the year ended December 31, 2003.  The income tax rate reduction results primarily from increased manufacturing in lower tax jurisdictions. 
As previously announced, the Company will conduct a conference call for financial analysts at 5:00 p.m., Eastern Time, today.  To hear the conference call, dial 800/233-2178.  A simultaneous webcast of the call may be accessed via the Company's website at www.stryker.com.  The call will be archived on this site for 90 days. A recording of the call will also be available from 7:00 p.m., Eastern Time, today until 7:00 p.m. on Saturday, July 17, 2004.  To hear this recording dial 800/633-8284 (domestic) or 402/977-9140 (international) and enter the registration number 21198803.  
Stryker Corporation is a leader in the worldwide orthopaedic market and is one of the world's largest medical device companies.  Stryker delivers results through a wide range of capabilities including joint replacements, trauma, spine and micro implant systems, orthobiologics, powered surgical instruments, surgical navigation systems and endoscopic products as well as patient handling and emergency medical equipment.  Stryker also provides outpatient physical therapy services in the United States.
Dean H. Bergy Vice President, Chief Financial Officer and Secretary 269/385-2600
Contact Information:
 
 
 
 
 
 
 
 


